BIOMAT Database Logo BIOMAT Database Logo

[Molecular Biological Aspects of Depressive Disorders: A Modern View]. 2020

V M Ushakova, and A Yu Morozova, and A M Reznik, and G P Kostyuk, and V P Chekhonin
Serbsky National Medical Research Center of Psychiatry and Narcology, Moscow, 119034 Russia.

Depression is a serious mental disorder that affects more than 300 million people worldwide. Due to the lack of effective treatment methods, the pathogenesis of depression is necessary to study in order to understand its development and find new therapies. The review describes the main mechanisms of depression, including the monoamine hypothesis, impairment of the hipotalamic-pituitary-adrenal axis, decreased production of neurotropic factors, and neuroinflammation. Genetic correlations, gene polymorphisms, and epigenetic mechanisms are also considered. Common and different features of the etiology are analyzed for depression and depressive conditions associated with other pathologies (schizophrenia, Parkinson disease, and Alzheimer's disease). Modern experimental methods used to investigate the molecular mechanisms of depressive conditions are described with a focus on gene knockouts in laboratory animals and the CRISPR/Cas technology. Consideration is given to optogenetic and chemogenetic methods and analyses of genetic polymorphisms and their combinations. The data may provide for a better integral understanding of the modern ideas about the pathogenesis of depression as an isolated or comorbid disorder and the prospects in studying the mechanisms of depressive conditions.

UI MeSH Term Description Entries
D011110 Polymorphism, Genetic The regular and simultaneous occurrence in a single interbreeding population of two or more discontinuous genotypes. The concept includes differences in genotypes ranging in size from a single nucleotide site (POLYMORPHISM, SINGLE NUCLEOTIDE) to large nucleotide sequences visible at a chromosomal level. Gene Polymorphism,Genetic Polymorphism,Polymorphism (Genetics),Genetic Polymorphisms,Gene Polymorphisms,Polymorphism, Gene,Polymorphisms (Genetics),Polymorphisms, Gene,Polymorphisms, Genetic
D003866 Depressive Disorder An affective disorder manifested by either a dysphoric mood or loss of interest or pleasure in usual activities. The mood disturbance is prominent and relatively persistent. Depression, Endogenous,Depression, Neurotic,Depression, Unipolar,Depressive Syndrome,Melancholia,Neurosis, Depressive,Unipolar Depression,Depressions, Endogenous,Depressions, Neurotic,Depressions, Unipolar,Depressive Disorders,Depressive Neuroses,Depressive Neurosis,Depressive Syndromes,Disorder, Depressive,Disorders, Depressive,Endogenous Depression,Endogenous Depressions,Melancholias,Neuroses, Depressive,Neurotic Depression,Neurotic Depressions,Syndrome, Depressive,Syndromes, Depressive,Unipolar Depressions
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D055785 Gene Knockdown Techniques The artificial induction of GENE SILENCING by the use of RNA INTERFERENCE to reduce the expression of a specific gene. It includes the use of DOUBLE-STRANDED RNA, such as SMALL INTERFERING RNA and RNA containing HAIRPIN LOOP SEQUENCE, and ANTI-SENSE OLIGONUCLEOTIDES. Gene Knock Down Techniques,Gene Knock Down,Gene Knock-Down,Gene Knock-Down Techniques,Gene Knockdown,Gene Knock Downs,Gene Knock-Down Technique,Gene Knock-Downs,Gene Knockdown Technique,Gene Knockdowns,Knock Down, Gene,Knock Downs, Gene,Knock-Down Technique, Gene,Knock-Down Techniques, Gene,Knock-Down, Gene,Knock-Downs, Gene,Knockdown Technique, Gene,Knockdown Techniques, Gene,Knockdown, Gene,Knockdowns, Gene,Technique, Gene Knock-Down,Technique, Gene Knockdown,Techniques, Gene Knock-Down,Techniques, Gene Knockdown
D064113 CRISPR-Cas Systems Adaptive antiviral defense mechanisms, in archaea and bacteria, based on DNA repeat arrays called CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEATS (CRISPR elements) that function in conjunction with CRISPR-ASSOCIATED PROTEINS (Cas proteins). Several types have been distinguished, including Type I, Type II, and Type III, based on signature motifs of CRISPR-ASSOCIATED PROTEINS. CRISPR Cas Systems,CRISPR-Cas System,System, CRISPR-Cas,Systems, CRISPR-Cas

Related Publications

V M Ushakova, and A Yu Morozova, and A M Reznik, and G P Kostyuk, and V P Chekhonin
[Molecular biological aspects of modern immunology (problems and perspectives)].
January 1979, Vestnik Akademii meditsinskikh nauk SSSR,
V M Ushakova, and A Yu Morozova, and A M Reznik, and G P Kostyuk, and V P Chekhonin
[Modern view on psychoneurotic disorders].
October 1952, Medicinski glasnik,
V M Ushakova, and A Yu Morozova, and A M Reznik, and G P Kostyuk, and V P Chekhonin
The modern treatment of depressive disorders.
June 1960, The American journal of psychiatry,
V M Ushakova, and A Yu Morozova, and A M Reznik, and G P Kostyuk, and V P Chekhonin
[MODERN VIEW ON CHILDREN'S BIOLOGICAL DEVELOPMENT].
January 2015, Gigiena i sanitariia,
V M Ushakova, and A Yu Morozova, and A M Reznik, and G P Kostyuk, and V P Chekhonin
[Biological aspects of depressive syndromes].
January 1961, Acta neurologica,
V M Ushakova, and A Yu Morozova, and A M Reznik, and G P Kostyuk, and V P Chekhonin
[Modern aspects of mood disorders].
January 1979, L'Encephale,
V M Ushakova, and A Yu Morozova, and A M Reznik, and G P Kostyuk, and V P Chekhonin
[Ontogenic aspects of depressive disorders].
January 2003, Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova,
V M Ushakova, and A Yu Morozova, and A M Reznik, and G P Kostyuk, and V P Chekhonin
[Immunological aspects of depressive disorders].
November 2007, Der Nervenarzt,
V M Ushakova, and A Yu Morozova, and A M Reznik, and G P Kostyuk, and V P Chekhonin
Biological aspects of modern dental composites.
January 2023, Biomaterial investigations in dentistry,
V M Ushakova, and A Yu Morozova, and A M Reznik, and G P Kostyuk, and V P Chekhonin
[Biological vulnerability to depressive disorders].
December 1994, L'Encephale,
Copied contents to your clipboard!